These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 8509869)
1. Quantification of myocardial muscarinic receptors with PET in humans. Delforge J; Le Guludec D; Syrota A; Bendriem B; Crouzel C; Slama M; Merlet P J Nucl Med; 1993 Jun; 34(6):981-91. PubMed ID: 8509869 [TBL] [Abstract][Full Text] [Related]
2. Noninvasive quantification of muscarinic receptors in vivo with positron emission tomography in the dog heart. Delforge J; Janier M; Syrota A; Crouzel C; Vallois JM; Cayla J; Lançon JP; Mazoyer BM Circulation; 1990 Oct; 82(4):1494-504. PubMed ID: 2401078 [TBL] [Abstract][Full Text] [Related]
3. Muscarinic receptor upregulation in patients with myocardial infarction: a new paradigm. Mazzadi AN; Pineau J; Costes N; Le Bars D; Bonnefoi F; Croisille P; Porcher R; Chevalier P Circ Cardiovasc Imaging; 2009 Sep; 2(5):365-72. PubMed ID: 19808624 [TBL] [Abstract][Full Text] [Related]
4. Modeling analysis of [11C]flumazenil kinetics studied by PET: application to a critical study of the equilibrium approaches. Delforge J; Syrota A; Bottlaender M; Varastet M; Loc'h C; Bendriem B; Crouzel C; Brouillet E; Maziere M J Cereb Blood Flow Metab; 1993 May; 13(3):454-68. PubMed ID: 8478404 [TBL] [Abstract][Full Text] [Related]
5. Muscarinic cholinergic receptor in the human heart evidenced under physiological conditions by positron emission tomography. Syrota A; Comar D; Paillotin G; Davy JM; Aumont MC; Stulzaft O; Maziere B Proc Natl Acad Sci U S A; 1985 Jan; 82(2):584-8. PubMed ID: 3871527 [TBL] [Abstract][Full Text] [Related]
6. In vivo quantification of myocardial muscarinic receptors in heart transplant patients. Le Guludec D; Delforge J; Syrota A; Desruennes M; Valette H; Gandjbakhch I; Merlet P Circulation; 1994 Jul; 90(1):172-8. PubMed ID: 8025993 [TBL] [Abstract][Full Text] [Related]
7. Kinetics of in vivo binding of antagonist to muscarinic cholinergic receptor in the human heart studied by positron emission tomography. Syrota A; Paillotin G; Davy JM; Aumont MC Life Sci; 1984 Aug; 35(9):937-45. PubMed ID: 6332257 [TBL] [Abstract][Full Text] [Related]
8. Quantification of benzodiazepine receptors in human brain using PET, [11C]flumazenil, and a single-experiment protocol. Delforge J; Pappata S; Millet P; Samson Y; Bendriem B; Jobert A; Crouzel C; Syrota A J Cereb Blood Flow Metab; 1995 Mar; 15(2):284-300. PubMed ID: 7860662 [TBL] [Abstract][Full Text] [Related]
9. Kinetic analysis of central [76Br]bromolisuride binding to dopamine D2 receptors studied by PET. Delforge J; Loc'h C; Hantraye P; Stulzaft O; Khalili-Varasteh M; Mazière M; Syrota A; Mazière B J Cereb Blood Flow Metab; 1991 Nov; 11(6):914-25. PubMed ID: 1834685 [TBL] [Abstract][Full Text] [Related]
10. Down-regulation of cardiac muscarinic receptors induced by di-isopropylfluorophosphate. Valette H; Syrota A; Fuseau C J Nucl Med; 1997 Sep; 38(9):1430-3. PubMed ID: 9293803 [TBL] [Abstract][Full Text] [Related]
11. Increased myocardial muscarinic receptor density in idiopathic dilated cardiomyopathy: an in vivo PET study. Le Guludec D; Cohen-Solal A; Delforge J; Delahaye N; Syrota A; Merlet P Circulation; 1997 Nov; 96(10):3416-22. PubMed ID: 9396436 [TBL] [Abstract][Full Text] [Related]
12. Imaging left ventricular muscarinic receptor heterogeneity: a tool to evaluate individuals at risk for sudden death? Caldwell JH; Link JM Circ Cardiovasc Imaging; 2009 Sep; 2(5):353-5. PubMed ID: 19808622 [No Abstract] [Full Text] [Related]
13. Cardiac beta-adrenergic receptor density measured in vivo using PET, CGP 12177, and a new graphical method. Delforge J; Syrota A; Lançon JP; Nakajima K; Loc'h C; Janier M; Vallois JM; Cayla J; Crouzel C J Nucl Med; 1991 Apr; 32(4):739-48. PubMed ID: 1672889 [TBL] [Abstract][Full Text] [Related]
14. Quantitation of extrastriatal D2 receptors using a very high-affinity ligand (FLB 457) and the multi-injection approach. Delforge J; Bottlaender M; Loc'h C; Guenther I; Fuseau C; Bendriem B; Syrota A; Mazière B J Cereb Blood Flow Metab; 1999 May; 19(5):533-46. PubMed ID: 10326721 [TBL] [Abstract][Full Text] [Related]
15. [3H]Pirenzepine and [3H]quinuclidinyl benzilate binding to brain muscarinic cholinergic receptors. Differences in measured receptor density are not explained by differences in receptor isomerization. Luthin GR; Wolfe BB Mol Pharmacol; 1984 Sep; 26(2):164-9. PubMed ID: 6548291 [TBL] [Abstract][Full Text] [Related]
16. Binding kinetics of quinuclidinyl benzilate and methyl-quinuclidinyl benzilate enantiomers at neuronal (M1), cardiac (M2), and pancreatic (M3) muscarinic receptors. Waelbroeck M; Tastenoy M; Camus J; Christophe J Mol Pharmacol; 1991 Sep; 40(3):413-20. PubMed ID: 1896027 [TBL] [Abstract][Full Text] [Related]
18. Stereoselective synthesis and biodistribution of potent [11C]-labeled antagonists for positron emission tomography imaging of muscarinic receptors in the airways. Visser TJ; van Waarde A; Jansen TJ; Visser GM; van der Mark TW; Kraan J; Ensing K; Vaalburg W J Med Chem; 1997 Jan; 40(1):117-24. PubMed ID: 9016336 [TBL] [Abstract][Full Text] [Related]
19. The distribution of the muscarinic acetylcholine receptor antagonists, quinuclidinyl benzilate and quinuclidinyl benzilate methiodide (both tritiated), in rat, guinea pig, and rabbit. Gibson RE; Eckelman WC; Vieras F; Reba RC J Nucl Med; 1979 Aug; 20(8):865-70. PubMed ID: 541735 [TBL] [Abstract][Full Text] [Related]
20. Quantitative evaluation of benzodiazepine receptors in live Papio papio baboons using positron emission tomography. Brouillet E; Chavoix C; Khalili-Varasteh M; Bottlaender M; Hantraye P; Yorke JC; Maziere M Mol Pharmacol; 1990 Oct; 38(4):445-50. PubMed ID: 2172764 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]